Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
2 of 2 filings we hold were filed after the two-business-day deadline. The furthest past the deadline was 193 business days late.
The 12 most recent Form 4 transactions.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
| Mangoceuticals, INC. |
| AGRANT◆ |
| 83,333 |
| — |
| — |
| — |
| Open the original filing on SEC.gov |
| Mar 16 | MGRX | Mangoceuticals, INC. | DTOISS◆ | 83,333 | — | — | — | Open the original filing on SEC.gov |
| Mar 16 | MGRX | Mangoceuticals, INC. | AGRANT◆ | 50,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 16 | MGRX | Mangoceuticals, INC. | DTOISS◆ | 50,000 | — | — | — | Open the original filing on SEC.gov |
| Sep 9, 2025 | MGRX | Mangoceuticals, INC. | AGRANT◆ | 2M | — | — | — | Open the original filing on SEC.gov |
| Sep 9, 2025 | MGRX | Mangoceuticals, INC. | AGRANT | 500,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 21, 2025 | MGRX | Mangoceuticals, INC. | AGRANT◆ | 50,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 21, 2025 | MGRX | Mangoceuticals, INC. | AGRANT◆ | — | — | — | — | Open the original filing on SEC.gov |
| Jun 5, 2025 | MGRX | Mangoceuticals, INC. | GGIFT | 200,000 | — | — | +33.1% | Open the original filing on SEC.gov |
| Jun 5, 2025 | MGRX | Mangoceuticals, INC. | GGIFT | 200,000 | — | — | -100.0% | Open the original filing on SEC.gov |